Oncternal Therapeutics, Inc.
Oncternal Therapeutics, Inc. is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
Oct 26, 2010Oncternal Therapeutics, Inc. is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
Mar 17, 2025SEC 25 delisting filing recorded for baseline coverage.
SourceC1260990 stopped trading
Mar 17, 2025C1260990 is linked to Oncternal Therapeutics, Inc. and ended with final status "delisted".
Source
Entity Graph
Oncternal Therapeutics, Inc.issuedC1260990
C1260990listed onOTHER
C1260990resulted inunknown
Source-Backed Claims
- Oncternal Therapeutics, Inc. received a notice from Nasdaq on November 22, 2024, regarding its status as a 'public shell.'8-K
- Nasdaq indicated that it would apply more stringent criteria to maintain Oncternal's listing due to the company's workforce reduction announcement on November 14, 2024.8-K
- Trading of Oncternal's common stock will be suspended at the opening of business on December 3, 2024, according to Nasdaq's notice.8-K
- Nasdaq will file a Form 25 Notification of Delisting with the SEC to remove Oncternal's securities from listing and registration.8-K
- Oncternal does not plan to appeal the Nasdaq determination regarding its delisting.8-K
Associated Tickers
Public-market security lifecycles tied to this issuer record.